Abstract
Selenides of substituted thiophene-3-carboxamide derivatives are designed and synthesized to explore their antiproliferative potential with EGFR inhibition. The excellent in vitro results present a novel hit molecule with EGFR kinase inhibition (nM).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have